MinervaBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7387.508 (Published 01 March 2003) Cite this as: BMJ 2003;326:508
Tamoxifen reduces the risk of breast cancer by about 50% in women at high risk. It also protects these women against benign breast disease, according to a new study (Journal of the National Cancer Institute 2003;95:302-7). Women who took tamoxifen in the original breast cancer prevention trial were 28% less likely than controls to get benign breast disease, and 29% less likely than controls to need a breast biopsy during an …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial